Agilent Technologies said on Monday it will acquire contract drug manufacturer Biovectra for $925 million to expand its portfolio of services offered to biotech companies and medical researchers.
Trending
- How AI can identify breast cancer ‘better’ than a doctor but there’s a catch | Science, Climate & Tech News
- 'Icky and heartbreaking': The $2 per hour worker behind the OnlyFans boom
- Is lekker lang uitslapen nou gezond, of juist niet?
- Maternity inquiry chair named in government U-turn
- British theatre is beating Broadway – but still has one massive problem | Ents & Arts News
- Iran war cost will be passed to consumers, shipping giant boss tells BBC
- Paralympics: Jules Segers and Aurélie Richard win medals in alpine skiing
- Fears grow for Iran’s women’s football team
